In this article, we will discuss: 11 Best Marijuana Stocks to Buy Right Now.
On March 23, 2026, Cannabis Business Times reported that bipartisan lawmakers introduced the Capital Lending and Investment for Marijuana Businesses (CLIMB) Act, which aims to provide financial access for cannabis enterprises in the United States. Representatives Troy Carter and Guy Reschenthaler sponsored the bill, which plans to allow state-approved operators to list on major US exchanges and acquire traditional banking services. Carter stated that “access to capital remains one of the biggest barriers,” stressing funding restrictions throughout the sector. The proposal would also provide safe harbor protections to financial institutions that offer loans, insurance, and investment services.
The law operates federal prohibition-related constraints that hinder U.S. operators compared with Canadian peers. Saphira Galoob, CEO of the US Cannabis Roundtable, stated that the law ensures equal chances for American cannabis entrepreneurs, while Boris Jordan described it as a “common-sense step” towards regulatory consistency. The measure also protects financial institutions that provide funds and services. Meanwhile, cannabis is still classified as a Schedule I substance, and President Donald Trump has ordered a prospective reclassification assessment, but no firm timeline has been provided.
With that said, here are the 11 Best Marijuana Stocks to Buy Right Now.
kostrez/Shutterstock.com
Methodology:
We used screeners to identify Best Marijuana Stocks and limited our final selection to companies that have recently reported noteworthy developments likely to impact investor sentiment. These stocks are also popular among analysts and elite hedge funds. Finally, we ranked these stocks in ascending order based on the number of hedge fund holders.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 427.7% since May 2014, beating its benchmark by 264 percentage points (see more details here).
11. Advanced Flower Capital Inc. (NASDAQ:AFCG)
Number of Hedge Fund Holders: 5
On March 4, 2026, Advanced Flower Capital Inc. (NASDAQ:AFCG) reported fourth-quarter 2025 GAAP net income of $0.9 million, or $0.04 per share, with distributable earnings of $(2.8) million, or ($0.12) per share. The corporation announced a full-year GAAP net loss of $(20.7) million, or $0.95 per share, while producing distributable earnings of $8.7 million, or $0.39 per share.
Advanced Flower Capital Inc. (NASDAQ:AFCG)’s CEO, Dan Neville, stated that the company focused on disciplined portfolio management and completed its BDC conversion in 2025 by resolving underperforming loans and reallocating capital to lower-middle-market enterprises. On March 2, 2026, the firm declared a cash dividend of $0.05 per common share for the first quarter of 2026, which will be paid on April 15, 2026, to shareholders of record as of March 31, 2026.
Advanced Flower Capital Inc. (NASDAQ:AFCG) offers commercial real estate finance services. Its primary business is to originate, structure, underwrite, and manage senior secured loans and other types of loans for established businesses in the cannabis market across states.
10. Organigram Global Inc. (NASDAQ:OGI)
Number of Hedge Fund Holders: 7
On March 5, 2026, Organigram Global Inc. (NASDAQ:OGI) reported the debut of SHRED Shotz, a 65ml single-serve cannabis beverage powered by its FAST nanoemulsion platform with a 15-minute onset. The corporation claims that SHRED generated more than $200 million in retail sales in 2025 and that the new product expands the brand into smaller serving sizes to reach new customers. Vice President Eric Williams stated that the launch incorporates user insights into product innovation while utilizing FAST technology for simplicity and predictability.
Organigram Global Inc. (NASDAQ:OGI) announced first-quarter fiscal 2026 gross revenue of $97.3 million and net revenue of $63.5 million, up 46% and 49% year-over-year, respectively, while producing adjusted EBITDA of $5.3 million, a 273% growth. According to CEO James Yamanaka, the corporation retained Canadian market leadership while improving efficiency, resulting in increased profitability through foreign expansion and operational discipline.
Organigram Global Inc. (NASDAQ:OGI) provides high-quality, indoor-grown cannabis to patients and adult recreational consumers, as well as develops international commercial alliances to expand the company’s global footprint.
9. Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI)
Number of Hedge Fund Holders: 7
On March 16, 2026, Oppenheimer lowered Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) to Perform from Outperform.
On March 12, 2026, Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) announced fourth-quarter and full-year 2025 results. The company noted strong portfolio expansion led by new originations. Co-CEO Peter Sack stated that the corporation maintained tight underwriting and shielded over 90% of its portfolio from interest rate reductions using fixed or variable rates with floors. The firm made $51.1 million in new loans and received $40.4 million in repayments from January 1 to March 12, 2026. The firm reported $98.4 million in drawn leverage at the end of the year and roughly $50.0 million in total liquidity as of March 12, 2026. The company expects a dividend payout ratio of 90% to 100% of distributable earnings in 2026. The firm has stated that it may declare a special dividend in the fourth quarter to meet taxable income distribution obligations.
Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) is a market-leading commercial mortgage REIT that uses extensive real estate, credit, and cannabis experience to originate senior secured loans primarily to state-licensed cannabis businesses in limited-license states across the United States.
8. Canopy Growth Corporation (NASDAQ:CGC)
Number of Hedge Fund Holders: 8
On March 27, 2026, Canaccord started coverage of Canopy Growth Corporation (NASDAQ:CGC) with a Buy rating and a price target of C$2.00. The company is regarded as a major cannabis company that operates in key worldwide adult-use and medical markets while creating and selling a diverse product portfolio. The analyst stated that the company is transitioning from an asset-light, third-party supply strategy to an asset-right, in-house supply model in an attempt to boost its worldwide competitiveness.
On March 16, 2026, Canopy Growth Corporation (NASDAQ:CGC) announced the completion of its acquisition of MTL Cannabis, resulting in one of Canada’s leading medical cannabis firms in terms of sales. The corporation stated that the transaction strengthens its Canadian infrastructure, expands its high-quality flower supply, and supports worldwide growth, notably in Europe. Management anticipates roughly $10 million in run-rate synergies within 18 months while integrating MTL’s promising operations to support a target of positive adjusted EBITDA in fiscal 2027.
Canopy Growth Corporation (NASDAQ:CGC) produces, sells, and distributes cannabis and products derived from cannabinoids for both medical and recreational use. The company operates in the following segments: Canada Cannabis, International Markets Cannabis, Storz and Bickel, This Works, and Other.
7. WM Technology, Inc. (NASDAQ:MAPS)
Number of Hedge Fund Holders: 9
On March 12, 2026, WM Technology, Inc. (NASDAQ:MAPS) announced fourth-quarter revenue of $43.1 million and full-year revenue of $174.7 million, a decrease from $47.7 million and $184.5 million, respectively. The firm cited pricing pressure and limited client investment in core markets. The corporation reported a $5.0 million net loss in the fourth quarter, down from $3.7 million the previous year, while adjusted EBITDA fell to $10.4 million from $11.9 million. The average monthly paying client dropped to 5,120, and revenue per client fell to $2,804 due to reduced spending and market turnover.
WM Technology, Inc. (NASDAQ:MAPS)’s full-year net income was $3.3 million, down from $12.2 million, and adjusted EBITDA fell to $39.8 million from $42.9 million, according to the company. CFO Susan Echard said that the firm started 2026 with solid liquidity, having cash of $62.4 million. CEO Doug Francis stated that the company maintained disciplined operations in the face of industry constraints while forecasting a sequential revenue decline of mid- to high-single digits in the first quarter of 2026.
WM Technology, Inc. (NASDAQ:MAPS) runs an online cannabis marketplace. It offers Weedmaps and Weedmaps for Business. It provides cannabis customers with information on cannabis dealers and brands.
6. GrowGeneration Corp. (NASDAQ:GRWG)
Number of Hedge Fund Holders: 11
On March 20, 2026, Alliance Global reduced its price objective for GrowGeneration Corp. (NASDAQ:GRWG) from $1.50 to $1.25 while keeping a Neutral rating, citing fourth-quarter revenue and EBITDA misses during a seasonally sluggish period. The analyst observed that proprietary brands accounted for 36% of Cultivation and Gardening sales. The analyst also said that the management anticipates profitability to improve through higher-margin owned brands and store consolidation, with a break-even EBITDA target in 2026 and a $10 million share repurchase program.
On March 19, 2026, GrowGeneration Corp. (NASDAQ:GRWG) announced fourth-quarter net sales of $37.8 million, up 1.0%, while expanding gross margin to 24.1% and lowering operating expenses by 44.4%, resulting in a net loss of $7.4 million and an adjusted EBITDA loss of $2.0 million. The corporation reported full-year net sales of $161.7 million, a net loss of $24.0 million, and an improved adjusted EBITDA loss of $6.0 million, while ending with $46.1 million in cash and no debt.
GrowGeneration Corp. (NASDAQ:GRWG) is involved in the development, marketing, retail, and distribution of hydroponic products and services. It operates in three segments: Cultivating and gardening, storage solutions, and corporate.
While we acknowledge the potential of GRWG to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than GRWG and that has 100x upside potential, check out our report about the cheapest AI stock.
Click to continue reading and see the 5 Best Marijuana Stocks to Buy Right Now.
Disclosure: None. Follow Insider Monkey on Google News.
